Viridian Therapeutics
VRDN
VRDN
27 hedge funds and large institutions have $5.05M invested in Viridian Therapeutics in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.43% less ownership
Funds ownership: 1.85% → 1.42% (-0.43%)
Holders
27
Holding in Top 10
1
Calls
$223K
Puts
–
Top Buyers
| 1 | +$446K | |
| 2 | +$428K | |
| 3 | +$332K | |
| 4 |
Renaissance Technologies
New York
|
+$62.6K |
| 5 |
Squarepoint
New York
|
+$30K |
Top Sellers
| 1 | -$139K | |
| 2 | -$72.6K | |
| 3 | -$48K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$42K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10K |